<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="L" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="L16008" Priority="1" Type="Secondary">Cell Biology</BookSubject>
          <BookSubject Code="L16010" Priority="2" Type="Secondary">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
            <Contact>
              <Email>d.gordon@bristol.ac.uk</Email>
            </Contact>
          </Editor>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>Neil J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
            <Contact>
              <Phone>+440177918-6632</Phone>
              <Email>n.j.scolding@tesco.net</Email>
            </Contact>
          </Editor>
          <Affiliation ID="AffID1">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="AffID2">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Part ID="Part2">
        <PartInfo OutputMedium="All" TocLevels="0">
          <PartID>2</PartID>
          <PartSequenceNumber>2</PartSequenceNumber>
          <PartTitle> Practical/Methodological Chapters</PartTitle>
          <PartChapterCount>13</PartChapterCount>
          <PartContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-931-4</BookID>
            <BookTitle>Neural Cell Transplantation</BookTitle>
          </PartContext>
        </PartInfo>
        <Chapter ID="Chap11" Language="En">
          <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
            <ChapterID>11</ChapterID>
            <ChapterNumber>11</ChapterNumber>
            <ChapterDOI>10.1007/978-1-60327-931-4_11</ChapterDOI>
            <ChapterSequenceNumber>11</ChapterSequenceNumber>
            <ChapterTitle Language="En">Animal Models of Multiple Sclerosis</ChapterTitle>
            <ChapterFirstPage>157</ChapterFirstPage>
            <ChapterLastPage>173</ChapterLastPage>
            <ChapterCopyright>
              <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
              <CopyrightYear>2009</CopyrightYear>
            </ChapterCopyright>
            <ChapterHistory>
              <RegistrationDate>
                <Year>2009</Year>
                <Month>1</Month>
                <Day>5</Day>
              </RegistrationDate>
              <OnlineDate>
                <Year>2009</Year>
                <Month>3</Month>
                <Day>23</Day>
              </OnlineDate>
            </ChapterHistory>
            <ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ChapterGrants><ChapterContext>
              <SeriesID>7651</SeriesID>
              <PartID>2</PartID>
              <BookID>978-1-60327-931-4</BookID>
              <BookTitle>Neural Cell Transplantation</BookTitle>
            </ChapterContext>
          </ChapterInfo>
          <ChapterHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1_11" CorrespondingAffiliationID="Aff1_11">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Roberto</GivenName>
                  <FamilyName>Furlan</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>furlan.roberto@hsr.it</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1_11">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Carmela</GivenName>
                  <FamilyName>Cuomo</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_11">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Gianvito</GivenName>
                  <FamilyName>Martino</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff1_11">
                <OrgDivision>Neuroimmunology Unit – DIBIT, Department of Neuroscience</OrgDivision>
                <OrgName>San Raffaele Scientific Institute</OrgName>
                <OrgAddress>
                  <Street>Via Olgettina 58</Street>
                  <Postcode>20132</Postcode>
                  <City>Milano</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1_11" Language="En" OutputMedium="All">
              <Heading>Summary</Heading>
              <Para>Since its first description, experimental autoimmune encephalomyelitis, originally designated experimental allergic encephalitis (EAE), has been proposed as animal model to investigate pathogenetic hypotheses and test new treatments in the field of central nervous system inflammation and demyelination, which has become, in the last 30 years, the most popular animal model of multiple sclerosis (MS). This experimental disease can be obtained in all mammals tested so far, including nonhuman primates, allowing very advanced preclinical studies. Its appropriate use has led to the development of the most recent treatments approved for MS, also demonstrating its predictive value when properly handled. Some of the most exciting experiments validating the use of neural precursor cells (NPCs) as a potential therapeutic option in CNS inflammation have been performed in this model. We review here the most relevant immunological features of EAE in the different animal species and strains, and describe detailed protocols to obtain the three most common clinical courses of EAE in mice, with the hope to provide both cultural and practical basis for the use of this fascinating animal model.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>
                <Emphasis Type="Bold">Key words:</Emphasis>
              </Heading>
              <Keyword>Experimental autoimmune encephalomyelitis</Keyword>
              <Keyword>Multiple sclerosis</Keyword>
              <Keyword>Disease induction.</Keyword>
            </KeywordGroup>
          </ChapterHeader>
          <Body>
            <Section1 ID="Sec1_11">
              <Heading>Introduction</Heading>
              <Para>Experimental autoimmune encephalomyelitis (EAE) is possibly the best animal model to study autoimmune diseases and in particular demyelinating diseases of the central nervous system (CNS) such as multiple sclerosis (MS). Since the first classical studies of Rivers (<CitationRef CitationID="CR1_11">1</CitationRef>), in monkeys immunized with CNS homogenate, EAE has been an invaluable tool for dissecting mechanisms of the immune response against self-antigens within the CNS, as well as to test new therapies for the treatment of autoimmune diseases. An autoimmune response leading to EAE in susceptible species can be obtained by means of active immunization with CNS proteins and by passive transfer of T lymphocytes reactingagainst myelin antigens to syngeneic recipients. The role of T lymphocytes in EAE was first demonstrated by Paterson who succeeded in transferring disease by means of T cells from immunized animals (<CitationRef CitationID="CR2_11">2</CitationRef>). Since then, many researchers have attempted to characterize the role of T cells in EAE. Over the years, it became clear that activated CD4+ T cells mediate EAE upon recognition of the target antigen bound to class II molecules of the major histocompatibility complex (MHC) (<CitationRef CitationID="CR3_11">3</CitationRef>). Encephalitogenic T cells can be retrieved from the blood of immunized as well as naive animals, supporting the concept that auto-aggressive lymphocytes are part of the natural immune repertoire (<CitationRef CitationID="CR4_11">4</CitationRef>, <CitationRef CitationID="CR5_11">5</CitationRef>).</Para>
              <Para>Several species and strains have been utilized including mice, rats, and guinea pigs. Virtually all mammalian species are susceptible to EAE as long as they are properly immunized. The clinical, pathological, and immunological picture of autoimmune models of demyelination depends upon the mode of sensitization, the nature of the immunogen, and the genetic background of each species and strain.</Para>
              <Para>Modes of sensitization include the route of immunization, primarily subcutaneously, and the use of immunogens emulsified with an equal volume of complete Freund’s adjuvant containing <Emphasis Type="Italic">Mycobacterium tubercolosis</Emphasis> to create an antigen depot. Boosts with <Emphasis Type="Italic">Bordetella pertussis</Emphasis> are often used to help in opening the blood–brain barrier (BBB).</Para>
              <Para>Whole myelin homogenate as well as distinct myelin proteins, including myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG), and proteolipid protein (PLP), have been used to induce EAE in different species. The role of MBP, an abundant hydrophilic myelin protein, was first characterized by Ben-Nun and colleagues, who successfully induced EAE by transferring MBP-specific T-cell lines to naive Lewis rats (<CitationRef CitationID="CR6_11">6</CitationRef>). Passive transfer studies also elucidated the role of other myelin antigens, including PLP (<CitationRef CitationID="CR7_11">7</CitationRef>) and MOG (<CitationRef CitationID="CR8_11">8</CitationRef>). MOG is a minor glycoprotein exposed on the surface of the myelin sheath and is the target of both humoral and cellular immune responses. The importance of the humoral response to MOG was first demonstrated by Linington who showed the presence of extensive demyelination following the injection of anti-MOG auto-antibodies into animals with T-cell-mediated EAE (<CitationRef CitationID="CR9_11">9</CitationRef>). Other encephalitogenic proteins include a lipidated form of MBP (<CitationRef CitationID="CR10_11">10</CitationRef>) as well as nonmyelin auto-antigens such as the astrocyte-derived calcium binding protein S100β (<CitationRef CitationID="CR11_11">11</CitationRef>).</Para>
              <Para>Depending upon the species, the antigen and the mode of sensitization, EAE may have a monophasic acute course (<Emphasis Type="Bold">Fig.</Emphasis>
                <InternalRef RefID="Fig1">1a</InternalRef>), as well as a chronic relapsing (<Emphasis Type="Bold">Fig.</Emphasis>
                <InternalRef RefID="Fig1">1b</InternalRef>) and even a primary progressive (<Emphasis Type="Bold">Fig.</Emphasis>
                <InternalRef RefID="Fig1">1c</InternalRef>) course that mimics human MS. The classical picture of acute EAE is characterized by perivascular inflammation mainly represented by CD4+ and CD8+ T lymphocytes and macrophages within the spinal cord and less consistently in the brain. Nevertheless, the manipulation of the above-mentioned factors can lead to a wide spectrum of neuropathological patterns inclusive of demyelination, remyelination, gliosis, loss of axons, and in certain species also necrosis (<CitationRef CitationID="CR12_11">12</CitationRef>).<Figure Category="Standard" Float="Yes" ID="Fig1">
                  <Caption Language="En">
                    <CaptionNumber>Fig. 1.</CaptionNumber>
                    <CaptionContent>
                      <SimplePara>EAE clinical courses.</SimplePara>
                    </CaptionContent>
                  </Caption>
                  <MediaObject>
                    <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-931-4_11_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                  </MediaObject>
                </Figure>
              </Para>
              <Section2 ID="Sec2_11">
                <Heading>EAE in Inbred
Species</Heading>
                <Para>Olitsky was the first to establish EAE in mice (<CitationRef CitationID="CR13_11">13</CitationRef>) and since then, thousands of scientists have used inbred rodents as the most suitable species for EAE studies. EAE has been successfully induced in guinea pigs (<CitationRef CitationID="CR14_11">14</CitationRef>) as well as in several strains of rats and mice. Some mice strains such as SJL/J develop a relapsing–remitting disease following active immunization with spinal cord homogenate (SCH) (<CitationRef CitationID="CR15_11">15</CitationRef>). Pathology shows the presence of mononuclear cell infiltrates within the CNS and demyelination. A similar disease can also be obtained by the adoptive transfer of MBP-specific T lymphocytes (<CitationRef CitationID="CR16_11">16</CitationRef>). In this H-2<Superscript>S</Superscript> strain, encephalitogenic T cells recognize few epitopes of MBP concentrated within the sequence 89–101, preferentially using the T-cell receptor (TCR) Vβ17 segment (<CitationRef CitationID="CR17_11">17</CitationRef>). A more restricted response to encephalitogenic determinants of MBP has been reported for H-2<Superscript>U</Superscript> mice susceptible to EAE such as PL/J and B.10.PL. Both encephalitogenic and nonencephalitogenic T cells recognize the N-terminal peptide Ac1-9 utilizing the same TCR Vβ8.2/Vα2 (or Vα<CitationRef CitationID="CR4_11">4</CitationRef>) gene combination (<CitationRef CitationID="CR3_11">3</CitationRef>). Interestingly, the same TCR gene segments are characteristic of the T-cell response to MBP in Lewis rats (<CitationRef CitationID="CR18_11">18</CitationRef>). In Lewis rats, EAE induced either by active immunization or by passive transfer of T cells is an acute monophasic disease mostly characterized by inflammation (<CitationRef CitationID="CR19_11">19</CitationRef>). In this species, EAE is mediated by CD4+ encephalitogenic T lymphocytes specific for the peptide 68–88, in the context of the class II molecule RT1.B<Superscript>1</Superscript>
(<CitationRef CitationID="CR20_11">20</CitationRef>), which rapidly home and persist at the site of inflammation (<CitationRef CitationID="CR21_11">21</CitationRef>). The dominant use of a restricted TCR repertoire has been successfully exploited in designing immunospecific therapies by means of anti-Vβ monoclonal antibodies (<CitationRef CitationID="CR22_11">22</CitationRef>) and active vaccination with epitopes of the encephalitogenic TCR molecule (<CitationRef CitationID="CR23_11">23</CitationRef>). Nevertheless, the presence of an epitope dominance, as well as limited TCR usage within the T-cell response to MBP, seems to be confined largely to the early phases of EAE and remains controversial in humans. Later stages of EAE are characterized by a more diverse recognition of previously cryptic determinants inside the MBP molecule (intramolecular spreading) and within other CNS antigens (intermolecular spreading) (<CitationRef CitationID="CR24_11">24</CitationRef>). The appearance of a diverse T-cell repertoire is further confirmed by the presence, in the spinal cord of rats with EAE, of a heterogeneous Vβ population during the recovery phase of disease (<CitationRef CitationID="CR25_11">25</CitationRef>). This may result from apoptosis of encephalitogenic T-cell clones (<CitationRef CitationID="CR26_11">26</CitationRef>) followed by secondary recruitment of activated cells from the recirculating T-cell pool specific for minor antigens.</Para>
                <Para>Recently, a chronic relapsing form of EAE has been successfully induced in Biozzi (AB/H) mice by immunization with SCH (<CitationRef CitationID="CR27_11">27</CitationRef>) or MOG (<CitationRef CitationID="CR28_11">28</CitationRef>). In this species, pathology shows the full spectrum of lesions seen in MS including sharp demyelination and remyelination. Another useful model was recently described in DA rats which are characterized by a chronic relapsing course, inflammation, and demyelination (<CitationRef CitationID="CR29_11">29</CitationRef>).</Para>
                <Para>In contrast to the rather restricted response to MBP, a diverse recognition of determinants within other myelin antigens, such as PLP (<CitationRef CitationID="CR30_11">30</CitationRef>) and MOG (<CitationRef CitationID="CR28_11">28</CitationRef>), seems to occur in most rodents. Although as a general rule for all inbred species it appears that strains of different haplotype react with different epitopes of myelin antigens.</Para>
                <Para>The presence of encephalitogenic T cells reacting against self-antigens in naive animals is of remarkable conceptual importance and supports the fact that autoaggressive T cells escaping thymic deletion are maintained within the normal circulating T-lymphocyte pool (<CitationRef CitationID="CR4_11">4</CitationRef>, <CitationRef CitationID="CR5_11">5</CitationRef>). A possible explanation for self-reactive T cells escaping negative selection has been recently clarified in an MBP−/− transgenic model in which endogenous MBP inactivated high avidity clones reacting against the immunodominant epitope making that determinant appear cryptic (<CitationRef CitationID="CR31_11">31</CitationRef>).</Para>
                <Para>Thus, other factors are also necessary to cause an autoimmune disease. The genetic background is a major factor conferring susceptibility to EAE and a number of murine loci have already been identified (<CitationRef CitationID="CR32_11">32</CitationRef>). Both MHC and non-MHC genes have been reported to control the development and severity of EAE (<CitationRef CitationID="CR33_11">33</CitationRef>). The role of environmental factors has been elegantly elucidated by Goverman and colleagues, who created transgenic mice expressing an MBP-specific TCR which spontaneously developed EAE only when challenged with microbial stimuli (<CitationRef CitationID="CR34_11">34</CitationRef>). In a similar model, the complete cohort of anti-MBP TCR transgenic mice, deficient for mature T and B cells, developed spontaneous EAE, suggesting that other cells may have a protective role counteracting with encephalitogenic cells (<CitationRef CitationID="CR35_11">35</CitationRef>). A protective and/or regulatory role has been claimed for almost all cells involved in the immune response including CD4+ T cells (<CitationRef CitationID="CR36_11">36</CitationRef>), CD8+ (<CitationRef CitationID="CR37_11">37</CitationRef>), CD4− CD8− (<CitationRef CitationID="CR38_11">38</CitationRef>), macrophages (<CitationRef CitationID="CR39_11">39</CitationRef>), B cells (<CitationRef CitationID="CR40_11">40</CitationRef>), γδ T cells (<CitationRef CitationID="CR41_11">41</CitationRef>), and NK cells (<CitationRef CitationID="CR42_11">42</CitationRef>).</Para>
                <Para>The environment exerts a major effect on EAE, leading to the activation of potentially autoaggressive T cells which consequently home to the brain and induce disease (<CitationRef CitationID="CR43_11">43</CitationRef>). Activation state is the necessary prerequisite for T cells to migrate through the BBB irrespective of their antigen specificity. Activation of myelin-specific T lymphocytes in the peripheral compartment can occur through a mechanism of molecular mimicry (<CitationRef CitationID="CR44_11">44</CitationRef>) and by stimulation with microbial superantigens (<CitationRef CitationID="CR45_11">45</CitationRef>). Other theoretical possibilities such as activation of T cells carrying two sets of receptors, one specific for a foreign protein and another for a self-antigen, has never been demonstrated to play a role in autoimmunity (<CitationRef CitationID="CR46_11">46</CitationRef>). Migration through the BBB requires the involvement of adhesion molecules on both T cells (LFA-1 and VLA-4) and endothelial cells (ICAM-1 and VCAM-1) (<CitationRef CitationID="CR47_11">47</CitationRef>). Following migration through the BBB, neuroantigen-specific CD4+ T cells are reactivated in situ by fragments of myelin antigens presented in the framework of MHC class II molecules on the surface of local antigen-presenting cells including macrophages, microglia, and less efficiently also by astrocytes (<CitationRef CitationID="CR48_11">48</CitationRef>). These events are associated with the release of proinflammatory cytokines leading to the up-regulation of MHC molecules on a variety of resident, antigen-presenting cells (<CitationRef CitationID="CR49_11">49</CitationRef>). The kinetics of cytokines along the EAE clinical course suggest the role of T-helper 1 (Th1) cytokines such as TNF-β, IL-12, TNF-α, and IFN-γ before and at the peak of disease. The recovery phase correlates with Th2 cytokines such as TGF-β, IL-10 and possiblyIL-4 (<CitationRef CitationID="CR50_11">50</CitationRef>). The onset of overt inflammation maintains also endothelial activation and leads to a second wave of inflammatory recruitment, including T cells, macrophages that result in tissue demage by means of TNF-α (<CitationRef CitationID="CR51_11">51</CitationRef>), oxygen and nitrogen intermediates, perforin, and complement (<CitationRef CitationID="CR52_11">52</CitationRef>) and demyelinating antibodies (<CitationRef CitationID="CR9_11">9</CitationRef>).</Para>
                <Para>Thus far, no consistent evidence differentiates between activated MBP-specific T lymphocytes with no encephalitogenic capabilities and their pathogenic counterparts, in spite of identical growing and stimulation conditions, sharing of epitope specificity and MHC restriction. Some studies suggest that differences in encephalitogenicity correlate with a predominant Th1 cytokine profile (<CitationRef CitationID="CR53_11">53</CitationRef>), their brain homing capacity (<CitationRef CitationID="CR54_11">54</CitationRef>), and the ability to mediate a delayed type hypersensitivity (DTH) response (<CitationRef CitationID="CR55_11">55</CitationRef>). Moreover, encephalitogenic T cells, despite their CD4+ phenotype, have been demonstrated to be cytotoxic for cells, such as astrocytes, presenting myelin antigens in an MHC-restricted manner (<CitationRef CitationID="CR56_11">56</CitationRef>). On the other hand, it has been suggested that nonencephalitogenic T cells can initiate autoimmune regulatory mechanisms through the production of IL-3 (<CitationRef CitationID="CR57_11">57</CitationRef>). It has been postulated that, at least in Lewis rats, encephalitogenicity of MBP-specific T cells correlates with the cytokine profile which depends on the MHC haplotype of the strain (<CitationRef CitationID="CR58_11">58</CitationRef>).</Para>
                <Para>A rather simplistic picture of the EAE cytokine network would suggest that TNF-α, TNF-β, IFN-γ, and IL-12 (proinflammatory cytokines) have a disease-promoting role, while TGF-β, IL-10, and possibly IL-4 (anti-inflammatory cytokines) may protect from disease. Although a detailed analysis of the current literature on this topic is far beyond the scope of this chapter, an enormous amount of date states that the real picture is much more complicated. Several factors influence the cytokine profile of effector and regulatory cells in EAE and, therefore, the final outcome of the immune response within the target organ. These include the age of the animal (<CitationRef CitationID="CR59_11">59</CitationRef>), nature of antigen-presenting cells (<CitationRef CitationID="CR60_11">60</CitationRef>, <CitationRef CitationID="CR61_11">61</CitationRef>), local cytokine micro-environment (<CitationRef CitationID="CR62_11">62</CitationRef>), selective engagement with co-stimulatory molecules (<CitationRef CitationID="CR63_11">63</CitationRef>), interaction with altered forms of the immunizing antigen (<CitationRef CitationID="CR64_11">64</CitationRef>), and the route of immunization (<CitationRef CitationID="CR65_11">65</CitationRef>).</Para>
                <Para>Based on the hypothesis that Th1 cytokines play a promoting effect on autoimmunity while Th2 cytokines may have a protective role, immune deviation toward a Th2 profile has been exploited forsuccessfully treating EAE by administration of anti-inflammatory cytokines (<CitationRef CitationID="CR66_11">66</CitationRef>), altered peptide ligands (<CitationRef CitationID="CR64_11">64</CitationRef>), monoclonal antibodies (MAb) affecting B7/CD28 interactions (<CitationRef CitationID="CR63_11">63</CitationRef>), anti-inflammatory cytokines (<CitationRef CitationID="CR67_11">67</CitationRef>, <CitationRef CitationID="CR68_11">68</CitationRef>), and by induction of oral tolerance (<CitationRef CitationID="CR65_11">65</CitationRef>). Despite the success of most of the experimental treatments targeting Th1 cytokines, the Th1 vs. Th2 dichotomy underscores the complexity of interactions that lead to reciprocal cross-regulation of Th1/Th2 responses. This has been dramatically elucidated by the severe aggravation of primates EAE due to an enhanced Th2 response occurring after discontinuation of treatment for immune deviation (<CitationRef CitationID="CR69_11">69</CitationRef>). Moreover, conflicting results arise from the utilization of genetically manipulated mice either lacking or over-expressing cytokines, as is the case in a number of TNF-α studies which demonstrated a different clinical phenotype depending on the experimental conditions. For example, over-expression of TNF-α in transgenic mice leads to spontaneous inflammation and demyelination within the CNS (<CitationRef CitationID="CR70_11">70</CitationRef>), while TNF-α-deficient knock-out mice can still develop EAE, thus challenging the role of this cytokine in EAE pathogenesis (<CitationRef CitationID="CR71_11">71</CitationRef>). Surprisingly, in a recent study, MOG-immunized, TNF-deficient mice developed a severe EAE but were remarkably ameliorated by the administration of TNF, also possibly supporting a protective role for this cytokine (<CitationRef CitationID="CR72_11">72</CitationRef>). Targeting cytokine genes has helped to elucidate the role of other cytokines, such as INF-γ (<CitationRef CitationID="CR73_11">73</CitationRef>), IL-4 and IL-10 (<CitationRef CitationID="CR74_11">74</CitationRef>), nitric oxide (<CitationRef CitationID="CR75_11">75</CitationRef>), and also on Fas/Fas-ligand and perforin pathways (<CitationRef CitationID="CR76_11">76</CitationRef>). Nevertheless, it must be kept in mind that results of genetic manipulation result in experimental conditions that only partially represent the in vivo situation and that apparently underscore the redundancy of the cytokine system.</Para>
                <Para>Overall, the deep knowledge of the immunogenetics of inbred species, the possibility of successfully manipulating it, together with their accessibility and costs, still make these species the first choice for studies on autoimmune diseases of the CNS.</Para>
              </Section2>
              <Section2 ID="Sec3_11">
                <Heading>EAE in Outbred
Species</Heading>
                <Para>EAE in nonhuman primates represented the first experimental model for demyelinating diseases of the CNS (<CitationRef CitationID="CR1_11">1</CitationRef>). The recent advances in housing and handling techniques, knowledge of primate anatomy, immunology, and genetics and the compatibility of most of human reagents and diagnostic techniques have sparked wide interest on EAE in these species. A unique advantage of monkeys arises from their outbred condition that closely resembles the human status. Moreover, the transfer of immunocompetent cells in outbred primates is allowed by the possibility of crossing the trans-species barrier among closely related species (<CitationRef CitationID="CR77_11">77</CitationRef>) and by the natural bone marrow chimerism in some others (<CitationRef CitationID="CR5_11">5</CitationRef>). Therefore, in primates it is possible to elucidate the role of pathogenic cells by means of passive transfer experiments in a polymorphic setting. Recently, EAE has been induced in the common marmoset <Emphasis Type="Italic">Callithrix jacchus</Emphasis>, a unique primate species that develops in utero as genetically distinct twins or triplets sharing bone marrow-derived elements through a common placental circulation (<CitationRef CitationID="CR78_11">78</CitationRef>). It has been recently demonstrated that <Emphasis Type="Italic">C. jacchus</Emphasis> TCR genes are extensively conserved (<CitationRef CitationID="CR79_11">79</CitationRef>) and that MHC class II region genes, despite a relatively low polymorphism, encode the evolutionary equivalents of the HLA-DR and -DQ molecules (<CitationRef CitationID="CR80_11">80</CitationRef>). A fully demyelinating form of EAE has been induced either by active immunization with whole myelin (<CitationRef CitationID="CR78_11">78</CitationRef>), myelin oligodendrocyte glycoprotein (MOG) or by MBP followed by administration of MOG-specific antibodies (<CitationRef CitationID="CR81_11">81</CitationRef>). Passive transfer experiments have demonstrated that encephalitogenic MBP-specific T cells are part of the normal marmoset repertoire (<CitationRef CitationID="CR5_11">5</CitationRef>). Similarly to humans, MBP-reactive T cells recognize different determinants by means of a diverse TCR repertoire (Antonio Uccelli, personal communication). Pathology of EAE induced with whole myelin or MOG is characterized by perivascular inflammation with conspicuous primary demyelination whose topography correlates with MRI abnormalities (<CitationRef CitationID="CR82_11">82</CitationRef>). On the contrary, immunization with MBP or passive transfer of MBP-reactive T cells leads to mild inflammation and no demyelination (<Emphasis Type="BoldItalic">5</Emphasis>, Mancardi and Uccelli unpublished results). A complex role of cytokines, possibly released by activated T lymphocytes and macrophages during the immune response, is suggested by the high expression of CD40 and CD40-ligands in marmoset active lesions (<CitationRef CitationID="CR83_11">83</CitationRef>). The role of Th1 cytokines has been demonstrated by the prevention of disease following treatment with the cAMP-specific type IV phosphodiesterase inhibitor Rolipram (<CitationRef CitationID="CR84_11">84</CitationRef>). On the other hand, the ambiguous role of Th2 cytokines was highlighted by the enhancement of EAE occurring after discontinuation of a MOG-based tolerization treatment due to an enhanced proliferative and antibodiesresponse to the antigen. Hence, it is likely that Th2-like T cells play a different role, protecting or favoring autoimmunity, under different conditions (<CitationRef CitationID="CR69_11">69</CitationRef>).</Para>
                <Para>EAE has also been induced in macaques by immunization with myelin or MBP emulsified in complete adjuvant (<CitationRef CitationID="CR85_11">85</CitationRef>). The EAE course is primarily hyperacute or acute, often with a lethal outcome, and is characterized by intense inflammation associated with hemorrhages and necrosis resembling acute disseminated encephalomyelitis (<CitationRef CitationID="CR86_11">86</CitationRef>). The association of EAE susceptibility with an MHC class II allele (<CitationRef CitationID="CR87_11">87</CitationRef>), the presence of myelin-reactive T cells correlating with the course of EAE (<CitationRef CitationID="CR86_11">86</CitationRef>), the beneficial effect of anti-CD4 antibodies on EAE outcome (<CitationRef CitationID="CR88_11">88</CitationRef>) and the possibility of inducing a mild form of EAE by adoptive transfer of MBP-specific T cells from unprimed animals (<CitationRef CitationID="CR89_11">89</CitationRef>) all provide strong evidence that T cells play a central role in this model. At the moment, the major advantage of a nonhuman primate EAE model for human MS resides in the molecular and functional organization of the primate immune system leading to the possibility of evaluating the safety and efficacy of biological molecules as therapy for MS.</Para>
              </Section2>
              <Section2 ID="Sec4_11">
                <Heading>Conclusions</Heading>
                <Para>EAE induced in mice and nonhuman primates represents a valuable tool to investigate novel therapeutic approaches in human MS, characterized by neural tissue damage occurring in the context of a very complex immune-mediated inflammatory reaction. In the following sections, we will describe the protocols to obtain (a) acute monophasic EAE (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig1">1a</InternalRef>) induced in SJL mice by immunization with SCH; (b) relapsing–remitting EAE (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig1">1b</InternalRef>) induced in SJL mice by immunization with PLP139–151; and (c) chronic-progressive EAE (<Emphasis Type="Bold">Fig.</Emphasis>
                  <Emphasis Type="Bold">1c</Emphasis>) induced in C57BL/6 mice by immunization with MOG35–55.</Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec5_11">
              <Heading>Materials</Heading>
              <Section2 ID="Sec6_11">
                <Heading>SCH Preparation</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>10-ml Glass syringes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>21-Gauge needles.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Surgical instruments for mouse dissection.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>4. 70-μm Falcon cell strainer.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Lyophilizer.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec7_11">
                <Heading>EAE Induction</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>10-ml Glass syringes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>30-ml Glass tubes (corex).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>21-Gauge needles.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Incomplete Freund’s Adjuvant (IFA) (Sigma).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Heat-inactivated, lyophilized <Emphasis Type="Italic">Mycobacterium tuberculosis</Emphasis> strain H37R (Beckton Dickinson, formerly DIFCO).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>1-ml Syringes with removable 25-gauge needle.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>MOG, residues 35–55 (MEVGWYRSPFSRVVHLYRNGK), or proteolipid proptein (PLP) residues 139–151 (HSLGKALGHPDKF) purity over 95% (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_11">1</InternalRef>), or SCH (see above).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Pertussis toxin (pancreatic islet activating) from <Emphasis Type="Italic">Bordetella pertussis</Emphasis> (Sigma).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Female C57BL/6 or SJL mice (depending on the antigen used), 18–20 g (6–8-weeks old).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec8_11">
              <Heading>Methods</Heading>
              <Section2 ID="Sec9_11">
                <Heading>SCH Preparation</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>SCH is prepared according to Levine and Sowinski (<CitationRef CitationID="CR91_11">90</CitationRef>). Using surgical scissors, take out cervical, thoracic, and lumbar column from sacrificed mice.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Firmly mount the 21-gauge needle on the 10-ml syringe filled with saline and flush out the spinal cords from the excised vertebral columns.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Homogenize the tissue by straining through the 70-μm Falcon cell strainer using a syringe piston.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Weigh the crude SCH and add saline 4:1 (w/v; es. 1,000 mg spinal cords with 250 μl saline).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Lyophilize according to the standard protocol of the available lyophilizer.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Store at −20°C.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec10_11">
                <Heading>EAE Induction</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>
                          <Emphasis Type="Italic">Emulsion preparation.</Emphasis> For the emulsion’s final volume, calculate 300 μl/mouse and at least 2–3 ml excess. In a glass tube, re-suspend the lyophilized antigen (MOG35–55, PLP139–151, or SCH) in 1× PBS at concentration indicated in <Emphasis Type="Bold">Table</Emphasis>
                          <InternalRef RefID="Tab1">1</InternalRef>
                          <Table Float="Yes" ID="Tab1">
                            <Caption Language="En">
                              <CaptionNumber>Table 1</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>Antigen concentrations and immunization schedules</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <tgroup cols="7">
                              <colspec colname="c0" colnum="0"/>
                              <colspec colname="c1" colnum="1"/>
                              <colspec colname="c2" colnum="2"/>
                              <colspec colname="c3" colnum="3"/>
                              <colspec colname="c4" colnum="4"/>
                              <colspec colname="c5" colnum="5"/>
                              <colspec colname="c6" colnum="6"/>
                              <thead>
                                <row>
                                  <entry colname="c0">
                                    <SimplePara>EAE type</SimplePara>
                                  </entry>
                                  <entry colname="c1">
                                    <SimplePara>Mouse strain</SimplePara>
                                  </entry>
                                  <entry colname="c2">
                                    <SimplePara>Antigen used</SimplePara>
                                  </entry>
                                  <entry colname="c3">
                                    <SimplePara>Antigen concentration</SimplePara>
                                  </entry>
                                  <entry colname="c4">
                                    <SimplePara>Sites of injection</SimplePara>
                                  </entry>
                                  <entry colname="c5">
                                    <SimplePara>P.T.</SimplePara>
                                  </entry>
                                  <entry colname="c6">
                                    <SimplePara>Boost</SimplePara>
                                  </entry>
                                </row>
                              </thead>
                              <tbody>
                                <row>
                                  <entry colname="c0">
                                    <SimplePara>Acute monophasic</SimplePara>
                                  </entry>
                                  <entry colname="c1">
                                    <SimplePara>SJL</SimplePara>
                                  </entry>
                                  <entry colname="c2">
                                    <SimplePara>SCH</SimplePara>
                                  </entry>
                                  <entry colname="c3">
                                    <SimplePara>27 mg/ml (4 mg/mouse)</SimplePara>
                                  </entry>
                                  <entry colname="c4">
                                    <SimplePara>The two hind footpads (approx. 50-μl each) and under the skin of the neck (remaining 200 μl)</SimplePara>
                                  </entry>
                                  <entry colname="c5">
                                    <SimplePara>400 ng/mouse the day of immunization and 48 h later</SimplePara>
                                  </entry>
                                  <entry colname="c6">
                                    <SimplePara>No</SimplePara>
                                  </entry>
                                </row>
                                <row>
                                  <entry colname="c0">
                                    <SimplePara>Relapsing–remitting</SimplePara>
                                  </entry>
                                  <entry colname="c1">
                                    <SimplePara>SJL</SimplePara>
                                  </entry>
                                  <entry colname="c2">
                                    <SimplePara>PLP139–151</SimplePara>
                                  </entry>
                                  <entry colname="c3">
                                    <SimplePara>2 mg/ml (300 μg/mouse)</SimplePara>
                                  </entry>
                                  <entry colname="c4">
                                    <SimplePara>Under the skin of one flank</SimplePara>
                                  </entry>
                                  <entry colname="c5">
                                    <SimplePara>500 ng/mouse the day of immunization and 48 h later</SimplePara>
                                  </entry>
                                  <entry colname="c6">
                                    <SimplePara>After seven days, injecting the emulsion on the opposite flank and repeating P.T. the day of the boost and 48 h later</SimplePara>
                                  </entry>
                                </row>
                                <row>
                                  <entry colname="c0">
                                    <SimplePara>Chronic</SimplePara>
                                  </entry>
                                  <entry colname="c1">
                                    <SimplePara>C57BL/6</SimplePara>
                                  </entry>
                                  <entry colname="c2">
                                    <SimplePara>MOG35-55</SimplePara>
                                  </entry>
                                  <entry colname="c3">
                                    <SimplePara>1.3 mg/ml (200 μg/mouse)</SimplePara>
                                  </entry>
                                  <entry colname="c4">
                                    <SimplePara>Under the skin of both flanks and at the tail base, 100 μl at each site</SimplePara>
                                  </entry>
                                  <entry colname="c5">
                                    <SimplePara>500 ng/mouse the day of immunization and 48 h later</SimplePara>
                                  </entry>
                                  <entry colname="c6">
                                    <SimplePara>No</SimplePara>
                                  </entry>
                                </row>
                              </tbody>
                            </tgroup>
                          </Table>(<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_11">2</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>In a second glass tube, prepare a homogeneous suspension of 8 mg/ml <Emphasis Type="Italic">M. tuberculosis</Emphasis> in IFA to obtain CFA. The lyophilized <Emphasis Type="Italic">M. tuberculosis</Emphasis> does not dissolve in IFA. An homogenous suspension can be obtained by careful stirring with a glass syringe, but <Emphasis Type="Italic">M. tuberculosis</Emphasis> will immediately re-precipitate at the bottom of the tube (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_11">3</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>In a third glass tube, mix the antigen, resuspended in PBS, and the CFA in a 1:1 volume ratio. Mix the emulsion by aspirating/expelling with a glass syringe through a 21-gauge needle until it becomes firm, dense, and very creamy (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_11">4</InternalRef>). This usually takes at least 5–10 min mixing.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>When the emulsion is ready, fill the 1-ml syringes by aspirating the emulsion through the 21-gauge needle you used to mix it, remove it, place back the original 25-gauge needle (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_11">5</InternalRef>). Then, swing the syringe in order to have the emulsion towards the piston and push the latter until the dead volume of the syringe is filled. If properly done, this will take you to have 900 μl emulsion in the syringe, exactly the amount needed for three mice.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Inject mice with the emulsion according to <Emphasis Type="Bold">Table</Emphasis>
                          <InternalRef RefID="Tab1">1</InternalRef> (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Notes</Emphasis>
                          <InternalRef RefID="Sec12_11">6</InternalRef> and <InternalRef RefID="Sec12_11">7</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Inject each mouse intravenously with P.T. re-suspended in 100 μl of PBS (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_11">8</InternalRef>), according to the dose and schedule indicated in <Emphasis Type="Bold">Table</Emphasis>
                          <InternalRef RefID="Tab1">1</InternalRef>.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec11_11">
                <Heading>EAE Clinical
Evaluation</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Clinical score and body weight is recorded daily.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Mice will have usually 1–2 g of weight loss in the days preceding clinical onset, which usually occurs, variably, between the 9th and 18th day after immunization.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>A nonparametric scale with five steps is used for clinical evaluation (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig2">2</InternalRef>
                          <Figure Category="Standard" Float="Yes" ID="Fig2">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 2.</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>EAE clinical evaluation.</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-931-4_11_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                            </MediaObject>
                          </Figure>). Mice are taken from the cage by the tail and observed from the abdominal side: healthy mice extend their hind limbs very wide when held in this position. An asymmetric position, especially with one of the hind limbs retracted close to the abdomen, may represent an initial sign of disease. A weak tail and an unsteady gait are the signs at onset. To reveal an uncertain gait, it is useful to observe mice walking on a grid, like the cage cover. Healthy mice are quick in movements on a grid almost as on firm ground. Sick mice are unsure, move slowly, and often stumble. In the absence of other signs, we score the uncertain gait on the cage cover as 1.5. Another useful examination is that of the righting reflex. Trying to put healthy mice on its back results in such a quick flipping to the upright position that it is impossible to see the abdomen. A sick mice may have a slow, very slow, to complete impaired righting reflex. In the absence of other signs, we score any grade of impairment of the righting reflex as 2. Paraparesis (score 3) and involvement of fore limbs (score 4) are easily identified (<Emphasis>see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec12_11">9</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec12_11">
              <Heading>Notes</Heading>
              <Para>
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para>Quality of the peptide is the most relevant issue to obtain a good disease. Incomplete incidence or very low severity of EAE are almost invariably related to peptide’s quality.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para>In order to avoid waste of material due to weighing procedures, we usually dissolve the lyophilized MOG35–55 or PLP139–151 peptide in 1× PBS at 2 mg/ml, sterilize by filtration on a 0.2-μm syringe filter (for in vitro immunological assays), and store it at –80°C in 1-ml aliquots for several months, up to 1 year, without loss of encephalitogenicity.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para>To improve the suspension, <Emphasis Type="Italic">M. tuberculosis</Emphasis> can be further triturated in a mortar with a pestel to obtain a more subtle powder, before mixing to IFA.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para>To check the emulsion’s quality, let a drop of it fall in water: a good emulsion stays compact without dissolving and without blurred edges.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para>Since the emulsion is very dense, a great pressure has to be applied to push the needed amount out of the syringe. This can lead to the popping off of the needle, and sometimes the emulsion comes out with great pressure and can get in the operator’s eyes. Therefore, great care has to be taken to put the 25-gauge needle back to the 1-ml syringe pressing it firmly. Additionally, the connection can be stabilized with a small piece of parafilm.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para>Mice should be housed in an SPF animal facility or, at least, in a clean conventional room since viral, bacterial, and especially parasitic infections can alter the disease course (Roberto Furlan personal observation).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para>Injections under the skin of the flanks is performed at the thoracic level to avoid the possibility to inject the emulsion intraperitoneally: consequent peritoneal inflammation leads to altered gait which is often confused with the clinical manifestation of EAE.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para>Pertussis toxin can be stored at −80°C in aliquots at the final concentration needed, for at least 6 months, with only a minor loss of activity.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>9.</ItemNumber>
                    <ItemContent>
                      <Para>When we have mice with grade 3 or 4 EAE, we put wet food pellets in the cage to allow paraplegic mice to eat and survive.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_Chapter_11.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ChapterBackmatter>
            <Bibliography ID="Bib1_11">
              <Heading>References</Heading>
              <Citation ID="CR1_11">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TM</Initials>
                    <FamilyName>Rivers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DH</Initials>
                    <FamilyName>Sprunt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GP</Initials>
                    <FamilyName>Berry</FamilyName>
                  </BibAuthorName>
                  <Year>1933</Year>
                  <ArticleTitle Language="En">Observations on the attempts to produce acutedisseminated encephalomyelitis in monkeys</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>58</VolumeID>
                  <FirstPage>39</FirstPage>
                  <LastPage>53</LastPage>
                  <Occurrence Type="PID">
                    <Handle>19870180</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.58.1.39</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BC3crhvFylsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rivers TM, Sprunt DH, Berry GP (1933) Observations on the attempts to produce acutedisseminated encephalomyelitis in monkeys. J Exp Med 58:39–53</BibUnstructured>
              </Citation>
              <Citation ID="CR2_11">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PY</Initials>
                    <FamilyName>Paterson</FamilyName>
                  </BibAuthorName>
                  <Year>1960</Year>
                  <ArticleTitle Language="En">Transfer of allergic encephalomyelitis in rats by means of lymph node cells</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>111</VolumeID>
                  <FirstPage>119</FirstPage>
                  <LastPage>135</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14430853</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.111.1.119</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaF3c7otlGltQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Paterson PY (1960) Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119–135</BibUnstructured>
              </Citation>
              <Citation ID="CR3_11">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Zamvil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Steinman</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">The T lymphocyte in experimental allergic encephalomyelitis</ArticleTitle>
                  <JournalTitle>Annu Rev Immunol</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>579</FirstPage>
                  <LastPage>621</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2188675</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1146/annurev.iy.08.040190.003051</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXkslGqsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zamvil SS and Steinman L (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579–621</BibUnstructured>
              </Citation>
              <Citation ID="CR4_11">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Schlusener</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wekerle</FamilyName>
                  </BibAuthorName>
                  <Year>1985</Year>
                  <ArticleTitle Language="En">Autoaggressive T-lymphocyte lines recognizing the encephalitogenic portion of myelin basic protein: in vitro selection from unprimed rat T-lymphocyte populations</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>135</VolumeID>
                  <FirstPage>3128</FirstPage>
                  <LastPage>3133</LastPage>
                </BibArticle>
                <BibUnstructured>Schlusener HJ and Wekerle H (1985) Autoaggressive T-lymphocyte lines recognizing the encephalitogenic portion of myelin basic protein: in vitro selection from unprimed rat T-lymphocyte populations. J Immunol 135:3128–3133</BibUnstructured>
              </Citation>
              <Citation ID="CR5_11">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Genain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lee-Parritz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Massacesi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Joshi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Ferrante</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hoffman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Moseley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NL</Initials>
                    <FamilyName>Letvin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Hauser</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">In healthy primate, circulating autoreactive T cells mediate autoimmune disease</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>94</VolumeID>
                  <FirstPage>1339</FirstPage>
                  <LastPage>1345</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7521889</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI117454</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2czmsFajtA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Genain CP, Lee-Parritz D, Nguyen MH, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley M, Letvin NL, Hauser SL (1994) In healthy primate, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest 4:1339–1345</BibUnstructured>
              </Citation>
              <Citation ID="CR6_11">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ben-Nun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wekerle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IR</Initials>
                    <FamilyName>Cohen</FamilyName>
                  </BibAuthorName>
                  <Year>1981</Year>
                  <ArticleTitle Language="En">The rapid isolation of clonable antigen specificT lymphocyte linescapable of mediating autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>195</FirstPage>
                  <LastPage>199</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6165588</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.1830110307</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL3M3ht1alsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ben-Nun A, Wekerle H, Cohen IR (1981) The rapid isolation of clonable antigen specificT lymphocyte linescapable of mediating autoimmune encephalomyelitis. Eur J Immunol 11:195–199</BibUnstructured>
              </Citation>
              <Citation ID="CR7_11">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Yamamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Namikawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Endoh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Kunishita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tabira</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Passive transfer of experimental allergic encephalomyelitis inducedby proteolipid apoprotein</ArticleTitle>
                  <JournalTitle>J Neurol Sci</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <FirstPage>269</FirstPage>
                  <LastPage>275</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3491880</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0022-510X(86)90174-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXmsFKrtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yamamura T, Namikawa T, Endoh M, Kunishita T, Tabira T (1986) Passive transfer of experimental allergic encephalomyelitis inducedby proteolipid apoprotein. J Neurol Sci 76:269–275</BibUnstructured>
              </Citation>
              <Citation ID="CR8_11">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Berger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Perry</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Weerth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Hinze-Selch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wekerle</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">T cell specific for the myelin oligodendrocyte glycoprotein (MOG) mediate an unusual autoimmune inflammatory response in the central nervous system</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>1364</FirstPage>
                  <LastPage>1372</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7684687</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.1830230627</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXltlOiurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu HC, Lassmann H, Wekerle H (1993) T cell specific for the myelin oligodendrocyte glycoprotein (MOG) mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23:1364–1372</BibUnstructured>
              </Citation>
              <Citation ID="CR9_11">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bradl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Brunner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Vass</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein</ArticleTitle>
                  <JournalTitle>Am J Pathol</JournalTitle>
                  <VolumeID>130</VolumeID>
                  <FirstPage>443</FirstPage>
                  <LastPage>454</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2450462</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL1c7mtFartA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443–454</BibUnstructured>
              </Citation>
              <Citation ID="CR10_11">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Massacesi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Vergelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Zehetbauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GM</Initials>
                    <FamilyName>Liuzzi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Olivotto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Ballerini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Uccelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Mancardi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Riccio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Amaducci</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form</ArticleTitle>
                  <JournalTitle>J Neurol Sci</JournalTitle>
                  <VolumeID>119</VolumeID>
                  <FirstPage>91</FirstPage>
                  <LastPage>98</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7504090</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0022-510X(93)90196-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXhs1WjtLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Massacesi L, Vergelli M, Zehetbauer B, Liuzzi GM, Olivotto J, Ballerini C, Uccelli A, Mancardi GL, Riccio P, Amaducci L (1993) Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form.J Neurol Sci 119:91–98</BibUnstructured>
              </Citation>
              <Citation ID="CR11_11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kojima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Berger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Hinze-Selch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Gehrmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Reske</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wekerle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>180</VolumeID>
                  <FirstPage>817</FirstPage>
                  <LastPage>829</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7520474</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.180.3.817</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXlsFGmtbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, Reske K, Wekerle H, Linington C (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J Exp Med 180:817–829</BibUnstructured>
              </Citation>
              <Citation ID="CR12_11">
                <CitationNumber>12.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Raine</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <NoChapterTitle/>
                  <BibEditorName>
                    <Initials>CS</Initials>
                    <FamilyName>Raine</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>HF</Initials>
                    <FamilyName>McFarl</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>WW</Initials>
                    <FamilyName>Tourtellotte</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis: a structural comparison Multiple sclerosis: clinical and pathogenetic basis</BookTitle>
                  <PublisherName>Chapman and Hall</PublisherName>
                  <PublisherLocation>London</PublisherLocation>
                  <FirstPage>242</FirstPage>
                  <LastPage>286</LastPage>
                </BibChapter>
                <BibUnstructured>Raine CS (1997) The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis: a structural comparison. In Raine CS, McFarland HF, Tourtellotte WW (eds) Multiple sclerosis: clinical and pathogenetic basis. Chapman and Hall, London, pp 242–286</BibUnstructured>
              </Citation>
              <Citation ID="CR13_11">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PK</Initials>
                    <FamilyName>Olitsky</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RH</Initials>
                    <FamilyName>Yager</FamilyName>
                  </BibAuthorName>
                  <Year>1949</Year>
                  <ArticleTitle Language="En">Experimental disseminated encephalomyelitis in mice</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>90</VolumeID>
                  <FirstPage>213</FirstPage>
                  <LastPage>223</LastPage>
                  <Occurrence Type="PID">
                    <Handle>18137295</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.90.3.213</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaH1M%2FjvVyksA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Olitsky PK and Yager RH (1949) Experimental disseminated encephalomyelitis in mice. J Exp Med 90:213–223</BibUnstructured>
              </Citation>
              <Citation ID="CR14_11">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RP</Initials>
                    <FamilyName>Lisak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Zweiman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Kies</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Driscoll</FamilyName>
                  </BibAuthorName>
                  <Year>1975</Year>
                  <ArticleTitle Language="En">Experimental allergic encephalomyelitis in resistant and susceptible guinea pigs: in vivo and in vitro correlates</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>114</VolumeID>
                  <FirstPage>546</FirstPage>
                  <LastPage>549</LastPage>
                  <Occurrence Type="PID">
                    <Handle>47353</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE2MXps1eqsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lisak RP, Zweiman B, Kies MW, Driscoll B (1975) Experimental allergic encephalomyelitis in resistant and susceptible guinea pigs: in vivo and in vitro correlates. J Immunol 114:546–549</BibUnstructured>
              </Citation>
              <Citation ID="CR15_11">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Brown</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>McFarlin</FamilyName>
                  </BibAuthorName>
                  <Year>1981</Year>
                  <ArticleTitle Language="En">Relapsing experimental allergic encephalomyelitis in the SJL/J mouse</ArticleTitle>
                  <JournalTitle>Lab Invest</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>278</FirstPage>
                  <LastPage>284</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6792424</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL38%2FhtFOrtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brown AM and McFarlin DE (1981) Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest 45:278–284</BibUnstructured>
              </Citation>
              <Citation ID="CR16_11">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Mokhtarian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>McFarlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Raine</FamilyName>
                  </BibAuthorName>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">Adoptive transfer of myelin basic proteinsensitized T-cells produces chronic relapsingdemyelinating disease in mice</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>309</VolumeID>
                  <FirstPage>356</FirstPage>
                  <LastPage>358</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6203039</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/309356a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2cXkt1Wmuro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mokhtarian F, McFarlin DE, Raine CS (1984) Adoptive transfer of myelin basic proteinsensitized T-cells produces chronic relapsingdemyelinating disease in mice. Nature 309:356–358</BibUnstructured>
              </Citation>
              <Citation ID="CR17_11">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Sakai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Sinha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Mitchell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Zamvil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Rothbard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HO</Initials>
                    <FamilyName>McDevitt</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nestedepitopes of myelin basic protein</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>85</VolumeID>
                  <FirstPage>8608</FirstPage>
                  <LastPage>8612</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2460872</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.85.22.8608</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXlsFOhsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sakai K, Sinha AA, Mitchell DJ, Zamvil SS, Rothbard JB, McDevitt HO (1988) Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nestedepitopes of myelin basic protein. Proc Natl Acad Sci USA 85:8608–8612</BibUnstructured>
              </Citation>
              <Citation ID="CR18_11">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FR</Initials>
                    <FamilyName>Burns</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RX</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Shen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Offner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Chou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Vandenbark</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Haber-Katz</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Both rats and mouse T-cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes even though the major hystocompatibility complex and encephalitogenic determinants being recognized are different</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>169</VolumeID>
                  <FirstPage>27</FirstPage>
                  <LastPage>39</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2462609</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.169.1.27</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXhsFagsbY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burns FR, Li RX, Shen L, Offner H, Chou K, Vandenbark A, Haber-Katz E (1989) Both rats and mouse T-cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes even though the major hystocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med 169:27–39</BibUnstructured>
              </Citation>
              <Citation ID="CR19_11">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Brunner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bradl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions</ArticleTitle>
                  <JournalTitle>Acta Neuropathol</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <FirstPage>566</FirstPage>
                  <LastPage>576</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3259787</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF00686201</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL1c3jvVSrtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75:566–576</BibUnstructured>
              </Citation>
              <Citation ID="CR20_11">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Vandenbark</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Offner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Reshef</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Fritz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Chou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IR</Initials>
                    <FamilyName>Cohen</FamilyName>
                  </BibAuthorName>
                  <Year>1985</Year>
                  <ArticleTitle Language="En">Specificity of T lymphocyte lines for peptides of myelin basic protein</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>139</VolumeID>
                  <FirstPage>229</FirstPage>
                  <LastPage>233</LastPage>
                </BibArticle>
                <BibUnstructured>Vandenbark AA, Offner H, Reshef T, Fritz RB, Chou C, Cohen IR (1985) Specificity of T lymphocyte lines for peptides of myelin basic protein. J Immunol 139:229–233</BibUnstructured>
              </Citation>
              <Citation ID="CR21_11">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Tanuma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Kojima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kohyama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Suzuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kawazoe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Matsumoto</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>160</VolumeID>
                  <FirstPage>509</FirstPage>
                  <LastPage>513</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9552010</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXhtFCgug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kim G, Tanuma N, Kojima T, Kohyama K, Suzuki Y, Kawazoe Y, Matsumoto Y (1998) CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis. J Immunol 160:509–513</BibUnstructured>
              </Citation>
              <Citation ID="CR22_11">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Zaller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Osman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Kanagawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hood</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Prevention and treatment of murine experiemental allergic encephalomyelitis with T-cell receptor Vβ specific antibodies</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>171</VolumeID>
                  <FirstPage>1943</FirstPage>
                  <LastPage>1955</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1693655</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.171.6.1943</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXksFOhsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zaller DM, Osman G, Kanagawa O, Hood L (1990) Prevention and treatment of murine experiemental allergic encephalomyelitis with T-cell receptor Vβ specific antibodies. J Exp Med 171:1943–1955</BibUnstructured>
              </Citation>
              <Citation ID="CR23_11">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Howell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Winters</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Olee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Powell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Carlo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SW</Initials>
                    <FamilyName>Brostoff</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Vaccination against experimental encephalomyelitis with T cell receptor peptides</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>246</VolumeID>
                  <FirstPage>668</FirstPage>
                  <LastPage>670</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2814489</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.2814489</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXnsV2jtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989) Vaccination against experimental encephalomyelitis with T cell receptor peptides. Science 246:668–670</BibUnstructured>
              </Citation>
              <Citation ID="CR24_11">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PV</Initials>
                    <FamilyName>Lehmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Forsthuber</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Miler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EE</Initials>
                    <FamilyName>Sercarz</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Spreading of T cell autoimmunity to cryptic determinants of an autoantigen</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>358</VolumeID>
                  <FirstPage>155</FirstPage>
                  <LastPage>157</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1377368</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/358155a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XkvVymsbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lehmann PV, Forsthuber T, Miler A, Sercarz EE (1992) Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155–157</BibUnstructured>
              </Citation>
              <Citation ID="CR25_11">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Offner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Buenafe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Vainiene</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Celnik</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AD</Initials>
                    <FamilyName>Weinberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DP</Initials>
                    <FamilyName>Gold</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Hashim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Vandenbark</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Where, when and how to detect biased expression of disease relevant Vβ genes in rats with experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>151</VolumeID>
                  <FirstPage>506</FirstPage>
                  <LastPage>517</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7686948</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXmt1Cjt74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Offner H, Buenafe AC, Vainiene M, Celnik B, Weinberg AD, Gold DP, Hashim G, Vandenbark AA (1993) Where, when and how to detect biased expression of disease relevant Vβ genes in rats with experimental autoimmune encephalomyelitis. J Immunol 151:506–517</BibUnstructured>
              </Citation>
              <Citation ID="CR26_11">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wekerle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Apoptosis in brain-specific autoimmune disease</ArticleTitle>
                  <JournalTitle>Curr Opinion Immunol</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>839</FirstPage>
                  <LastPage>843</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0952-7915(95)80057-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XnsFKjtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bauer J, Wekerle H, Lassmann H (1995) Apoptosis in brain-specific autoimmune disease. Curr Opinion Immunol 7:839–843</BibUnstructured>
              </Citation>
              <Citation ID="CR27_11">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JK</Initials>
                    <FamilyName>O’Neill</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Gschmeissner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CE</Initials>
                    <FamilyName>Wilcox</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Butter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Turk</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice</ArticleTitle>
                  <JournalTitle>J Nueroimmunol</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>261</FirstPage>
                  <LastPage>270</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0165-5728(90)90019-J</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3czisVersQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baker D, O’Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL (1990) Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Nueroimmunol 28:261–270</BibUnstructured>
              </Citation>
              <Citation ID="CR28_11">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Amor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Groome</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Morris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Dornmair</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MV</Initials>
                    <FamilyName>Gardinier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Matthieu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>153</VolumeID>
                  <FirstPage>4349</FirstPage>
                  <LastPage>4356</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7525700</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXit1eqsro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153:4349–4356</BibUnstructured>
              </Citation>
              <Citation ID="CR29_11">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JC</Initials>
                    <FamilyName>Lorentzen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Issazadeh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Storch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MI</Initials>
                    <FamilyName>Mustafa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Klareskog</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Olsson</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Protracted relapsing and demyelinating experimental autoimmune encephalomyelitis in DA tats immunized with syngeneic spinal cord and incomplete Freund’s adjuvant</ArticleTitle>
                  <JournalTitle>J Neuroimmunol</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>193</FirstPage>
                  <LastPage>205</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8550817</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0165-5728(95)00153-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXhtVSgtL7J</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lorentzen JC, Issazadeh S, Storch M, Mustafa MI, Lassman H, Linington C, Klareskog L, Olsson T (1995) Protracted relapsing and demyelinating experimental autoimmune encephalomyelitis in DA tats immunized with syngeneic spinal cord and incomplete Freund’s adjuvant. J Neuroimmunol 63:193–205</BibUnstructured>
              </Citation>
              <Citation ID="CR30_11">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Greer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Sobel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Sette</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Southwood</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MB</Initials>
                    <FamilyName>Lees</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VK</Initials>
                    <FamilyName>Kuchroo</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>156</VolumeID>
                  <FirstPage>371</FirstPage>
                  <LastPage>379</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8598487</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XlsV2r</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK (1996) Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 156:371–379</BibUnstructured>
              </Citation>
              <Citation ID="CR31_11">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>OS</Initials>
                    <FamilyName>Targoni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PV</Initials>
                    <FamilyName>Lehmann</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Endogenous myelin basic protein inactivates the high avidity T cell repertoire</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>187</VolumeID>
                  <FirstPage>2055</FirstPage>
                  <LastPage>2063</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9625765</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.187.12.2055</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXktVeitrc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Targoni OS, Lehmann PV (1998) Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med 187:2055–2063</BibUnstructured>
              </Citation>
              <Citation ID="CR32_11">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Sundvall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Jirholt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HT</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Jansson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Engstrom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Pettersson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Holmdahl</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Identification of murine loci associatedwith susceptibility to chronic experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>Nat Genet</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>313</FirstPage>
                  <LastPage>317</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7545492</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/ng0795-313</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXms1KjtbY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sundvall M, Jirholt J, Yang HT, Jansson L, Engstrom A, Pettersson U, Holmdahl R (1995) Identification of murine loci associatedwith susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet 10:313–317</BibUnstructured>
              </Citation>
              <Citation ID="CR33_11">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Weissert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Wallstrom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MK</Initials>
                    <FamilyName>Storch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Stefferl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lorentzen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Olsson</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">MHC haplotype-dependent regulation of MOG-induced EAE in rats</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>102</VolumeID>
                  <FirstPage>1265</FirstPage>
                  <LastPage>1273</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9739061</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI3022</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmtFyhtr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Weissert R, Wallstrom E, Storch MK, Stefferl A, Lorentzen J, Lassmann H, Linington C, Olsson T (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102:1265–1273</BibUnstructured>
              </Citation>
              <Citation ID="CR34_11">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Goverman J Woods</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Larson L Weiner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hood</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Zaller</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity</ArticleTitle>
                  <JournalTitle>Cell</JournalTitle>
                  <VolumeID>72</VolumeID>
                  <FirstPage>551</FirstPage>
                  <LastPage>560</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0092-8674(93)90074-Z</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Goverman J Woods A, Larson L Weiner LP, Hood L, Zaller DM (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551–560</BibUnstructured>
              </Citation>
              <Citation ID="CR35_11">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lafaille</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nagashima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Katsuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tonegawa</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice</ArticleTitle>
                  <JournalTitle>Cell</JournalTitle>
                  <VolumeID>78</VolumeID>
                  <FirstPage>399</FirstPage>
                  <LastPage>408</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7520367</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0092-8674(94)90419-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXlsFGmt7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lafaille J, Nagashima K, Katsuki M, Tonegawa S (1994) High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399–408</BibUnstructured>
              </Citation>
              <Citation ID="CR36_11">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Kumar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EE</Initials>
                    <FamilyName>Sercarz</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen induced autoimmune disease</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>178</VolumeID>
                  <FirstPage>909</FirstPage>
                  <LastPage>916</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7688792</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.178.3.909</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXlsl2jt7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kumar V, Sercarz EE (1993) The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen induced autoimmune disease. J Exp Med 178: 909–916</BibUnstructured>
              </Citation>
              <Citation ID="CR37_11">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Jiang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SI</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Pernis</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Role of CD8+ T cells in murine experimental allergic encephalomyelitis</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>256</VolumeID>
                  <FirstPage>1213</FirstPage>
                  <LastPage>1215</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1375398</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.256.5060.1213</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK383ntFamtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jiang H, Zhang SI, Pernis B (1992) Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256:1213–1215</BibUnstructured>
              </Citation>
              <Citation ID="CR38_11">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MF</Initials>
                    <FamilyName>Kozovska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Yamamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tabira</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">T-T cell interaction between CD4-CD8- regulatory T-cells and T cell clones presenting TCR peptide. Its implications for TCR vaccination against experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>157</VolumeID>
                  <FirstPage>1781</FirstPage>
                  <LastPage>1790</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8759768</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XkvFWgtrc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kozovska MF, Yamamura T, Tabira T (1996) T-T cell interaction between CD4-CD8- regulatory T-cells and T cell clones presenting TCR peptide. Its implications for TCR vaccination against experimental autoimmune encephalomyelitis. J Immunol 157:1781–1790</BibUnstructured>
              </Citation>
              <Citation ID="CR39_11">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Huitinga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Van Rooijen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJA</Initials>
                    <FamilyName>De Groot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BMJ</Initials>
                    <FamilyName>Uitdehaag</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CD</Initials>
                    <FamilyName>Dijkstra</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Suppression of experimental allergic encephalomyelitis in Lewis rats aftre elimination of macrophages</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>172</VolumeID>
                  <FirstPage>1025</FirstPage>
                  <LastPage>1033</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2145387</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.172.4.1025</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3M%2FhtFansA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Huitinga I, Van Rooijen N, De Groot CJA, Uitdehaag BMJ, Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats aftre elimination of macrophages. J Exp Med 172:1025–1033</BibUnstructured>
              </Citation>
              <Citation ID="CR40_11">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Wolf</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BN</Initials>
                    <FamilyName>Dittel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Hardardottir</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Janaway</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Experimental autoimmune encephalomyelitis induction in genetically B-cell deficient mice</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>184</VolumeID>
                  <FirstPage>2271</FirstPage>
                  <LastPage>2278</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8976182</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.184.6.2271</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2s7jtVCiuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wolf SD, Dittel BN, Hardardottir F, Janaway CA (1996) Experimental autoimmune encephalomyelitis induction in genetically B-cell deficient mice. J Exp Med 184:2271–2278</BibUnstructured>
              </Citation>
              <Citation ID="CR41_11">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kobayashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Kaway</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Ito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Honda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Sobue</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Yoshikai</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor γδ-specific antibodies</ArticleTitle>
                  <JournalTitle>J Neuroimmunol</JournalTitle>
                  <VolumeID>73</VolumeID>
                  <FirstPage>169</FirstPage>
                  <LastPage>174</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9058773</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0165-5728(96)00187-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXht1Kntrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kobayashi Y, Kaway K, Ito K, Honda H, Sobue G, Yoshikai Y (1997) Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor γδ-specific antibodies. J Neuroimmunol 73:169–174</BibUnstructured>
              </Citation>
              <Citation ID="CR42_11">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BN</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Yamamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Kondo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Fujiwara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tabira</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>186</VolumeID>
                  <FirstPage>1677</FirstPage>
                  <LastPage>1687</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9362528</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.186.10.1677</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnsVeitr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang BN, Yamamura T, Kondo T, Fujiwara M, Tabira T (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186:1677–1687</BibUnstructured>
              </Citation>
              <Citation ID="CR43_11">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Naparstek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ben-Nun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Holoshitz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Reshef</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Frenkel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rosenberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IR</Initials>
                    <FamilyName>Cohen</FamilyName>
                  </BibAuthorName>
                  <Year>1983</Year>
                  <ArticleTitle Language="En">T lymphocyte line producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>418</FirstPage>
                  <LastPage>423</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6189728</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.1830130513</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL3s3gvFyitQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Naparstek Y, Ben-Nun A, Holoshitz J, Reshef T, Frenkel A, Rosenberg M, Cohen IR (1983) T lymphocyte line producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol 13:418–423</BibUnstructured>
              </Citation>
              <Citation ID="CR44_11">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Ufret-Vincenty</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Quigley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Tresser</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Pak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gado</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hausmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KW</Initials>
                    <FamilyName>Wucherpfennig</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Brocke</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">In Vivo Survival of Viral Antigen-specific T Cells that Induce Experimental Autoimmune Encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Exp Med 1998</JournalTitle>
                  <VolumeID>188</VolumeID>
                  <FirstPage>1725</FirstPage>
                  <LastPage>1738</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.188.9.1725</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXntFOmt78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ufret-Vincenty RL, Quigley L, Tresser N, Pak SH, Gado A, Hausmann S, Wucherpfennig KW, Brocke S (1998) In Vivo Survival of Viral Antigen-specific T Cells that Induce Experimental Autoimmune Encephalomyelitis. J Exp Med 1998 188:1725–1738</BibUnstructured>
              </Citation>
              <Citation ID="CR45_11">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Brocke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gaur</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Piercy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gautam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Gijbels</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GC</Initials>
                    <FamilyName>Fathman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Steinman</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>365</VolumeID>
                  <FirstPage>642</FirstPage>
                  <LastPage>644</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7692305</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/365642a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXms1yku7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman GC, Steinman L (1993) Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365:642–644</BibUnstructured>
              </Citation>
              <Citation ID="CR46_11">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Padovan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Giachino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Cella</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Valitutti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Acuto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lanzavecchia</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Normal T lymphocytes can express two different T cell receptor β chains: implications for the mechanism of allelic exclusion</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>181</VolumeID>
                  <FirstPage>1587</FirstPage>
                  <LastPage>1591</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7699339</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.181.4.1587</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXkslWntbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Padovan E, Giachino C, Cella M, Valitutti S, Acuto O, Lanzavecchia A (1995) Normal T lymphocytes can express two different T cell receptor β chains: implications for the mechanism of allelic exclusion. J Exp Med 181:1587–1591</BibUnstructured>
              </Citation>
              <Citation ID="CR47_11">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Cannella</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Cross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Raine</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Upregulation and coexpression of adhesion molecules correlates with experimental autoimmune demyelination in the central nervous system</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>172</VolumeID>
                  <FirstPage>1521</FirstPage>
                  <LastPage>1524</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2172438</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.172.5.1521</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXlslShsLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cannella B, Cross AH, Raine CS (1990) Upregulation and coexpression of adhesion molecules correlates with experimental autoimmune demyelination in the central nervous system. J Exp Med 172:1521–1524</BibUnstructured>
              </Citation>
              <Citation ID="CR48_11">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Myers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Dougherty</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ron</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>2252</FirstPage>
                  <LastPage>2260</LastPage>
                </BibArticle>
                <BibUnstructured>Myers KJ, Dougherty JP, Ron Y (1993) In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J Immunol 15:2252–2260</BibUnstructured>
              </Citation>
              <Citation ID="CR49_11">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Traugott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>McFarlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Raine</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse</ArticleTitle>
                  <JournalTitle>Cell Immunol</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>394</FirstPage>
                  <LastPage>410</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0008-8749(86)90248-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Traugott U, McFarlin DE, Raine CS (1986) Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell Immunol 99:394–410</BibUnstructured>
              </Citation>
              <Citation ID="CR50_11">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Olsson</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>Eur J Neurol</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>7</FirstPage>
                  <LastPage>19</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1468-1331.1994.tb00045.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Olsson T (1994) Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur J Neurol 1:7–19</BibUnstructured>
              </Citation>
              <Citation ID="CR51_11">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KW</Initials>
                    <FamilyName>Selmaj</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Raine</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro</ArticleTitle>
                  <JournalTitle>Ann Neurol</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>339</FirstPage>
                  <LastPage>46</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3132891</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ana.410230405</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1cXitVejtLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339–46</BibUnstructured>
              </Citation>
              <Citation ID="CR52_11">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Compston</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NJ</Initials>
                    <FamilyName>Scolding</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Immune-mediated oligodendrocyte injury</ArticleTitle>
                  <JournalTitle>Ann N Y Acad Sci</JournalTitle>
                  <VolumeID>633</VolumeID>
                  <FirstPage>196</FirstPage>
                  <LastPage>204</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1789547</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1749-6632.1991.tb15610.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK387mtFGnsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Compston DA, Scolding NJ (1991) Immune-mediated oligodendrocyte injury. Ann N Y Acad Sci 633:196–204</BibUnstructured>
              </Citation>
              <Citation ID="CR53_11">
                <CitationNumber>53.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>YM</Initials>
                    <FamilyName>Conboy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>DeKruyff</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Tate</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ZA</Initials>
                    <FamilyName>Cao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Moore</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DT</Initials>
                    <FamilyName>Umetsu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PP</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>185</VolumeID>
                  <FirstPage>439</FirstPage>
                  <LastPage>451</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9053444</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.185.3.439</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXhtFWnsbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Conboy YM, DeKruyff R, Tate KM, Cao ZA, Moore TA, Umetsu DT, Jones PP (1997) Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains. J Exp Med 185:439–451</BibUnstructured>
              </Citation>
              <Citation ID="CR54_11">
                <CitationNumber>54.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Baron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Madri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NH</Initials>
                    <FamilyName>Ruddle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Hashim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Janaway</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>177</VolumeID>
                  <FirstPage>57</FirstPage>
                  <LastPage>68</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7678116</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.177.1.57</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXlsl2quw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baron JL, Madri JA, Ruddle NH, Hashim G, Janaway CA (1993) Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177:57–68</BibUnstructured>
              </Citation>
              <Citation ID="CR55_11">
                <CitationNumber>55.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Beraud</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Balzano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Zamora</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Varriale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Bernard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ben-Nun</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties</ArticleTitle>
                  <JournalTitle>J Neuroimmunol</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>41</FirstPage>
                  <LastPage>54</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7690770</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0165-5728(93)90283-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXhtVCgsbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Beraud E, Balzano C, Zamora AJ, Varriale S, Bernard D, Ben-Nun A (1993) Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties. J Neuroimmunol 47:41–54</BibUnstructured>
              </Citation>
              <Citation ID="CR56_11">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Sun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wekerle</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presentig astrocytes</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>320</VolumeID>
                  <FirstPage>70</FirstPage>
                  <LastPage>72</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2419764</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/320070a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL287ks1yktA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sun D, Wekerle H (1986) Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presentig astrocytes. Nature 320:70–72</BibUnstructured>
              </Citation>
              <Citation ID="CR57_11">
                <CitationNumber>57.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Jeong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Itzikson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Uccelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Brocke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Oksenberg</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Differential display analysis of murine encephalitogenic mRNA</ArticleTitle>
                  <JournalTitle>Int Immunol</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>1819</FirstPage>
                  <LastPage>1823</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9885902</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/intimm/10.12.1819</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXlvF2rsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jeong MC, Itzikson L, Uccelli A, Brocke S, Oksenberg JR (1998) Differential display analysis of murine encephalitogenic mRNA. Int Immunol 10:1819–1823</BibUnstructured>
              </Citation>
              <Citation ID="CR58_11">
                <CitationNumber>58.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Mustafa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Vingsbo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Olsson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ljungdhal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Hojeberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Holmdahl</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">The major histocompatibility complex influences myelin basic protein 68–86-induced T-cell cytokine profile and experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>3089</FirstPage>
                  <LastPage>3095</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7504988</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.1830231207</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXlt1CktQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mustafa M, Vingsbo C, Olsson T, Ljungdhal A, Hojeberg B, Holmdahl R (1993) The major histocompatibility complex influences myelin basic protein 68–86-induced T-cell cytokine profile and experimental autoimmune encephalomyelitis. Eur J Immunol 23:3089–3095</BibUnstructured>
              </Citation>
              <Citation ID="CR59_11">
                <CitationNumber>59.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Forsthuber</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Yip</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PV</Initials>
                    <FamilyName>Lehmann</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Induction of TH1 and TH2 immunity in neonatal mice</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>271</VolumeID>
                  <FirstPage>1728</FirstPage>
                  <LastPage>1730</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8596934</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.271.5256.1728</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhvVajs7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Forsthuber T, Yip HC, Lehmann PV (1996) Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728–1730</BibUnstructured>
              </Citation>
              <Citation ID="CR60_11">
                <CitationNumber>60.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Krakowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Owens</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <FirstPage>2840</FirstPage>
                  <LastPage>2847</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9394808</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.1830271115</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnt1OjsLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Krakowski ML, Owens T (1997) The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Eur J Immunol 27:2840–2847</BibUnstructured>
              </Citation>
              <Citation ID="CR61_11">
                <CitationNumber>61.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Aloisi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Ria</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Penna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Adorini</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>160</VolumeID>
                  <FirstPage>4671</FirstPage>
                  <LastPage>4680</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9590212</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjtVansLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Aloisi F, Ria F, Penna G, Adorini L (1998) Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160:4671–4680</BibUnstructured>
              </Citation>
              <Citation ID="CR62_11">
                <CitationNumber>62.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Falcone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Bloom</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>185</VolumeID>
                  <FirstPage>901</FirstPage>
                  <LastPage>907</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9120396</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.185.5.901</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXhsFKns7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Falcone M, Bloom BR (1997) A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med 185:901–907</BibUnstructured>
              </Citation>
              <Citation ID="CR63_11">
                <CitationNumber>63.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VK</Initials>
                    <FamilyName>Kuchroo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MP</Initials>
                    <FamilyName>Das</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Brown</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Ranger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Zamvil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Sobel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Weiner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Nabavi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Glimcher</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy</ArticleTitle>
                  <JournalTitle>Cell</JournalTitle>
                  <VolumeID>80</VolumeID>
                  <FirstPage>707</FirstPage>
                  <LastPage>718</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7534215</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0092-8674(95)90349-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXksVahs78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707–718</BibUnstructured>
              </Citation>
              <Citation ID="CR64_11">
                <CitationNumber>64.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LB</Initials>
                    <FamilyName>Nicholson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Greer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Sobel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MB</Initials>
                    <FamilyName>Lees</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VK</Initials>
                    <FamilyName>Kuchroo</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>Immunity</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>397</FirstPage>
                  <LastPage>405</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7584131</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/1074-7613(95)90169-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXovFyms7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nicholson LB, Greer JM, Sobel RA, Lees MB, Kuchroo VK (1995) An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397–405</BibUnstructured>
              </Citation>
              <Citation ID="CR65_11">
                <CitationNumber>65.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Weiner</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Oral tolerance: immune mechanisms and treatment of autoimmune diseases</ArticleTitle>
                  <JournalTitle>Immunol Today</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>335</FirstPage>
                  <LastPage>343</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9238837</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0167-5699(97)01053-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXks1als7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Weiner HL (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335–343</BibUnstructured>
              </Citation>
              <Citation ID="CR66_11">
                <CitationNumber>66.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MK</Initials>
                    <FamilyName>Racke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Bonomo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>Scott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Cannella</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Levine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Raine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Shevach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rocken</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>180</VolumeID>
                  <FirstPage>1961</FirstPage>
                  <LastPage>1966</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7525845</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.180.5.1961</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmt1ymsro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Rocken M (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961–1966</BibUnstructured>
              </Citation>
              <Citation ID="CR67_11">
                <CitationNumber>67.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>NH</Initials>
                    <FamilyName>Ruddle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Bergman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>McGrath</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EG</Initials>
                    <FamilyName>Lingenheld</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Grunnet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Padula</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Clark</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>172</VolumeID>
                  <FirstPage>1193</FirstPage>
                  <LastPage>1200</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2212948</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.172.4.1193</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXlslSitb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172:1193–1200</BibUnstructured>
              </Citation>
              <Citation ID="CR68_11">
                <CitationNumber>68.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Leonard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Waldburger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Goldman</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>181</VolumeID>
                  <FirstPage>381</FirstPage>
                  <LastPage>386</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7528773</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.181.1.381</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXisl2rs7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leonard JP, Waldburger KE, Goldman SJ (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181:381–386</BibUnstructured>
              </Citation>
              <Citation ID="CR69_11">
                <CitationNumber>69.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Genain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Abel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Belmar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Villinger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DP</Initials>
                    <FamilyName>Rosenberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Raine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Hauser</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Late complications of immune deviation therapy in a nonhuman primate</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>274</VolumeID>
                  <FirstPage>2054</FirstPage>
                  <LastPage>2057</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8953031</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.274.5295.2054</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXjtV2k</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL (1996) Late complications of immune deviation therapy in a nonhuman primate. Science 274:2054–2057</BibUnstructured>
              </Citation>
              <Citation ID="CR70_11">
                <CitationNumber>70.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Taupin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Renno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Bourbonniere</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Peterson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rodriguez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Owens</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <FirstPage>905</FirstPage>
                  <LastPage>913</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9130643</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.1830270416</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXislShsbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Taupin V, Renno T, Bourbonniere L, Peterson AC, Rodriguez M, Owens T (1997) Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur J Immunol 27:905–913</BibUnstructured>
              </Citation>
              <Citation ID="CR71_11">
                <CitationNumber>71.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Frei</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HP</Initials>
                    <FamilyName>Eugster</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bopst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CS</Initials>
                    <FamilyName>Constantinescu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Lavi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Fontana</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>185</VolumeID>
                  <FirstPage>2177</FirstPage>
                  <LastPage>2182</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9182689</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.185.12.2177</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXktVers7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Frei K, Eugster HP, Bopst M, Constantinescu CS, Lavi E, Fontana A (1997) Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 185:2177–2182</BibUnstructured>
              </Citation>
              <Citation ID="CR72_11">
                <CitationNumber>72.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Marino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Wong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Grail</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Dunn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bettadapura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Slavin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Old</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Bernard</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>78</FirstPage>
                  <LastPage>83</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9427610</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nm0198-078</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjt1Kgsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4:78–83</BibUnstructured>
              </Citation>
              <Citation ID="CR73_11">
                <CitationNumber>73.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>IA</Initials>
                    <FamilyName>Ferber</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Brocke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Taylor-Edwards</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Ridgway</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Dinisco</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Steinman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Dalton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CG</Initials>
                    <FamilyName>Fathman</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>156</VolumeID>
                  <FirstPage>5</FirstPage>
                  <LastPage>7</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8598493</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XlsVGj</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG (1996) Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156:5–7</BibUnstructured>
              </Citation>
              <Citation ID="CR74_11">
                <CitationNumber>74.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Bettelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MP</Initials>
                    <FamilyName>Das</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ED</Initials>
                    <FamilyName>Howard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Weiner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Sobel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VK</Initials>
                    <FamilyName>Kuchroo</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>161</VolumeID>
                  <FirstPage>3299</FirstPage>
                  <LastPage>3306</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9759845</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmsFWntb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK (1998) IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161:3299–3306</BibUnstructured>
              </Citation>
              <Citation ID="CR75_11">
                <CitationNumber>75.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>UC</Initials>
                    <FamilyName>Sahrbacher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Lechner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HP</Initials>
                    <FamilyName>Eugster</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Frei</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Fontana</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>1332</FirstPage>
                  <LastPage>1338</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9565373</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1521-4141(199804)28:04&lt;1332::AID-IMMU1332&gt;3.0.CO;2-G</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXitlWntrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sahrbacher UC, Lechner F, Eugster HP, Frei K, Lassmann H, Fontana A (1998) Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol 28:1332–1338</BibUnstructured>
              </Citation>
              <Citation ID="CR76_11">
                <CitationNumber>76.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Malipiero</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Frei</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KS</Initials>
                    <FamilyName>Spanaus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Agresti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hahne</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Tschopp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HP</Initials>
                    <FamilyName>Eugster</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Fontana</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <FirstPage>3151</FirstPage>
                  <LastPage>3160</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9464800</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.1830271211</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXisF2nsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Malipiero U, Frei K, Spanaus KS, Agresti C, Lassmann H, Hahne M, Tschopp J, Eugster HP, Fontana A (1997) Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur J Immunol 27:3151–3160</BibUnstructured>
              </Citation>
              <Citation ID="CR77_11">
                <CitationNumber>77.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Bontrop</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Otting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Slierendregt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Lanchbury</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates</ArticleTitle>
                  <JournalTitle>Immunol Rev</JournalTitle>
                  <VolumeID>143</VolumeID>
                  <FirstPage>43</FirstPage>
                  <LastPage>62</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1600-065X.1995.tb00669.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bontrop RE, Otting N, Slierendregt BL, Lanchbury JS (1995) Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates. Immunol Rev 143:43–62</BibUnstructured>
              </Citation>
              <Citation ID="CR78_11">
                <CitationNumber>78.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Massacesi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Genain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lee-Parritz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NL</Initials>
                    <FamilyName>Letvin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Canfield</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL.</Initials>
                    <FamilyName>Hauser</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Chronic relapsing experimental autoimmune encephalomyelitis in new world primates</ArticleTitle>
                  <JournalTitle>Ann Neurol</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <FirstPage>519</FirstPage>
                  <LastPage>530</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7717689</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ana.410370415</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2M3jtlOguw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Massacesi L, Genain CP, Lee-Parritz D Letvin NL, Canfield D, Hauser SL. (1995) Chronic relapsing experimental autoimmune encephalomyelitis in new world primates. Ann Neurol 37:519–530</BibUnstructured>
              </Citation>
              <Citation ID="CR79_11">
                <CitationNumber>79.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Uccelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Oksenberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Jeong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Genain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Rombos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Jaeger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lanchbury</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Hauser</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>158</VolumeID>
                  <FirstPage>1201</FirstPage>
                  <LastPage>1207</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9013960</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXitFWmsL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Uccelli A, Oksenberg JR, Jeong M, Genain CP, Rombos T, Jaeger E, Lanchbury J, Hauser SL (1997) Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. J Immunol 158:1201–1207</BibUnstructured>
              </Citation>
              <Citation ID="CR80_11">
                <CitationNumber>80.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SG</Initials>
                    <FamilyName>Antunes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NG</Initials>
                    <FamilyName>de Groot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Brok</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Doxiadis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Menezes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Otting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Bontrop</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">The Common Marmoset: a new world primate species with limited MHC class II variability</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci U S A</JournalTitle>
                  <VolumeID>95</VolumeID>
                  <FirstPage>11745</FirstPage>
                  <LastPage>11750</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9751736</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.95.20.11745</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmsV2hsrc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Antunes SG, de Groot NG, Brok H, Doxiadis G, Menezes AA, Otting N, Bontrop RE (1998) The Common Marmoset: a new world primate species with limited MHC class II variability. Proc Natl Acad Sci U S A 95:11745–11750</BibUnstructured>
              </Citation>
              <Citation ID="CR81_11">
                <CitationNumber>81.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Genain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NL</Initials>
                    <FamilyName>Letvin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Pearl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Adelman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MB</Initials>
                    <FamilyName>Lees</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Linington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Hauser</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Antibody facilitation of multiple sclerosis-like lesions in a non-human primate</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>96</VolumeID>
                  <FirstPage>2966</FirstPage>
                  <LastPage>2974</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8675668</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI118368</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XmtVemsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman L, Lees MB, Linington C, Hauser SL (1995) Antibody facilitation of multiple sclerosis-like lesions in a non-human primate. J Clin Invest 96:2966–2974</BibUnstructured>
              </Citation>
              <Citation ID="CR82_11">
                <CitationNumber>82.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Hart</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Muller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Melchers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nicolay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Brok</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Bontrop</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Massacesi</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (<Emphasis Type="Italic">Callithrix jacchus</Emphasis>)</ArticleTitle>
                  <JournalTitle>Am J Pathol</JournalTitle>
                  <VolumeID>153</VolumeID>
                  <FirstPage>649</FirstPage>
                  <LastPage>663</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9708823</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0002-9440(10)65606-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1cznt1Gmtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hart BA, Bauer J, Muller HJ, Melchers B, Nicolay K, Brok H, Bontrop RE, Lassmann H, Massacesi L (1998) Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (<Emphasis Type="Italic">Callithrix jacchus</Emphasis>). Am J Pathol 153:649–663</BibUnstructured>
              </Citation>
              <Citation ID="CR83_11">
                <CitationNumber>83.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Laman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>van Meurs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Schellekens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>de Boer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Melchers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Massacesi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Claassen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>‘t Hart</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (<Emphasis Type="Italic">Callithrix jacchus</Emphasis>)</ArticleTitle>
                  <JournalTitle>J Neuroimmunol</JournalTitle>
                  <VolumeID>86</VolumeID>
                  <FirstPage>30</FirstPage>
                  <LastPage>45</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9655470</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0165-5728(98)00024-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjsVensrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Laman JD, van Meurs M, Schellekens MM, de Boer M, Melchers B, Massacesi L, Lassmann H, Claassen E, ‘t Hart BA (1998) Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (<Emphasis Type="Italic">Callithrix jacchus</Emphasis>). J Neuroimmunol 86:30–45</BibUnstructured>
              </Citation>
              <Citation ID="CR84_11">
                <CitationNumber>84.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Genain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Roberts</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Uccelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Faulds</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hoffman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Timmel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Ferrante</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Joshi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Hedgpeth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Hauser</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Prevention of autoimmune demyelination in non-human primates by a cAmp-specific phosphodiesterase inhibitor</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <FirstPage>3601</FirstPage>
                  <LastPage>3605</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7536938</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.92.8.3601</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXltFSmsb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Genain CP, Roberts T, Davis R, Nguyen M, Uccelli A, Faulds D, Hoffman K, Timmel G, Li, Y, Ferrante R, Joshi N, Hedgpeth J, Hauser SL (1995) Prevention of autoimmune demyelination in non-human primates by a cAmp-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 92:3601–3605</BibUnstructured>
              </Citation>
              <Citation ID="CR85_11">
                <CitationNumber>85.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Shaw</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EC</Initials>
                    <FamilyName>Alvord</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hruby</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Chronic remitting–relapsing experimental allergic encephalomyelitis induced in monkeys with homologous myelin basic protein</ArticleTitle>
                  <JournalTitle>Ann Neurol</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>738</FirstPage>
                  <LastPage>748</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2462850</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ana.410240608</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL1M%2FoslWitA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shaw CM, Alvord EC, Hruby S (1988) Chronic remitting–relapsing experimental allergic encephalomyelitis induced in monkeys with homologous myelin basic protein. Ann Neurol 24:738–748</BibUnstructured>
              </Citation>
              <Citation ID="CR86_11">
                <CitationNumber>86.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Massacesi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Joshi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Lee-Parritz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Rombos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NL</Initials>
                    <FamilyName>Letvin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Hauser</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>90</VolumeID>
                  <FirstPage>399</FirstPage>
                  <LastPage>404</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1379611</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI115874</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38Xls12gt7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Massacesi L, Joshi N, Lee-Parritz D, Rombos A, Letvin NL, Hauser SL (1992) Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. J Clin Invest 90:399–404</BibUnstructured>
              </Citation>
              <Citation ID="CR87_11">
                <CitationNumber>87.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Slierendregt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>‘t Hart</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Otting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Anholts</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Verduin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Claas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Jonker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Lanchbury</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Bontrop</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques</ArticleTitle>
                  <JournalTitle>Int Immunol</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>1671</FirstPage>
                  <LastPage>1679</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8562513</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/intimm/7.10.1671</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXptVWqsLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Slierendregt BL, Hall M, ‘t Hart B, Otting N, Anholts J, Verduin W, Claas F, Jonker M, Lanchbury JS, Bontrop RE (1995) Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques. Int Immunol 7:1671–1679</BibUnstructured>
              </Citation>
              <Citation ID="CR88_11">
                <CitationNumber>88.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Van Lambalgen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Jonker</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Experimental allergic encephalomyelitis in the rhesus monkey. Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies</ArticleTitle>
                  <JournalTitle>Clin Exp Immunol</JournalTitle>
                  <VolumeID>67</VolumeID>
                  <FirstPage>305</FirstPage>
                  <LastPage>312</LastPage>
                </BibArticle>
                <BibUnstructured>Van Lambalgen R, Jonker M (1987) Experimental allergic encephalomyelitis in the rhesus monkey. Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies. Clin Exp Immunol 67:305–312</BibUnstructured>
              </Citation>
              <Citation ID="CR89_11">
                <CitationNumber>89.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Meinl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Hoch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Dornmair K de Waal Malefyt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Bontrop</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Jonker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Lassmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Hohlfeld</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wekerle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>‘t Hart</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Differential encephalitogenic potential of myelin basic protein-specific T cell isolated from normal rhesus macaques</ArticleTitle>
                  <JournalTitle>Am J Pathol</JournalTitle>
                  <VolumeID>150</VolumeID>
                  <FirstPage>445</FirstPage>
                  <LastPage>453</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9033260</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXhtlSgtr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Meinl E, Hoch RM, Dornmair K de Waal Malefyt R, Bontrop RE, Jonker M, Lassmann H, Hohlfeld R, Wekerle H, ‘t Hart B (1997) Differential encephalitogenic potential of myelin basic protein-specific T cell isolated from normal rhesus macaques. Am J Pathol 150:445–453</BibUnstructured>
              </Citation>
              <Citation ID="CR91_11">
                <CitationNumber>90.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Levine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Sowinski</FamilyName>
                  </BibAuthorName>
                  <Year>1973</Year>
                  <ArticleTitle Language="En">Experimental allergic encephalomyelitis in inbred and outbred mice</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>110</VolumeID>
                  <FirstPage>139</FirstPage>
                  <LastPage>43</LastPage>
                  <Occurrence Type="PID">
                    <Handle>4631068</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaE3s%2FptFSjtA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Levine S, Sowinski R (1973) Experimental allergic encephalomyelitis in inbred and outbred mice. J Immunol 110:139–43</BibUnstructured>
              </Citation>
              <Citation ID="CR90_11">
                <CitationNumber>90.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Theiler</FamilyName>
                  </BibAuthorName>
                  <Year>1934</Year>
                  <ArticleTitle Language="En">Spontaneous encephalomyelitis of mice: a new virus disease</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>80</VolumeID>
                  <FirstPage>122</FirstPage>
                  <Occurrence Type="PID">
                    <Handle>17750712</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.80.2066.122-a</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BC3cvmvFChtA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Theiler M (1934) Spontaneous encephalomyelitis of mice: a new virus disease. Science 80:122</BibUnstructured>
              </Citation>
            </Bibliography>
          </ChapterBackmatter>
        </Chapter>
      </Part>
    </Book>
  </Series>
</Publisher>